MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

Osteogenesis Imperfecta

  1. Home
  2. Diseases
  3. Osteogenesis Imperfecta
  4. Clinical Trials

Clinical Trials Related to Osteogenesis Imperfecta

Related studies linked through entity extraction aliases.

NCT00705120

Treatment of Severe Osteogenesis Imperfecta by Allogeneic Bone Marrow Transplantation

Status
COMPLETED
Phase
PHASE1

NCT00655681

Prevention of Post Operative Bone Loss in Children

Status
COMPLETED
Phase
NA

NCT00187018

Marrow Mesenchymal Cell Therapy for Osteogenesis Imperfecta: A Pilot Study

Status
COMPLETED
Phase
NA

NCT00159419

Bisphosphonate Therapy for Osteogenesis Imperfecta

Status
COMPLETED
Phase
PHASE4

NCT00131469

Study of Teriparatide (FORTEO) to Treat Adults With Osteogenesis Imperfecta

Status
COMPLETED
Phase
PHASE4

NCT00131118

Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis Imperfecta

Status
COMPLETED
Phase
PHASE2

NCT00106028

Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children

Status
COMPLETED
Phase
PHASE3

NCT00076830

Evaluation and Treatment of Patients With Connective Tissue Disease

Status
COMPLETED
Phase
N/A

NCT00063479

Bisphosphonate Treatment of Osteogenesis Imperfecta

Status
COMPLETED
Phase
PHASE2

NCT00005901

Pamidronate to Treat Osteogenesis Imperfecta in Children

Status
COMPLETED
Phase
PHASE3

NCT00001594

Evaluation and Intervention for the Effects of Osteogenesis Imperfecta

Status
COMPLETED
Phase
N/A

NCT00001305

Growth Hormone Therapy in Osteogenesis Imperfecta

Status
COMPLETED
Phase
PHASE3
Previous

Next

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.